| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocardia, Inc. (BCDA) has 9 insiders with recent SEC Form 4 filings, including 14 buys and 0 sells. BCDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 293.3K | $283.5K | - | |
| CFO | 106.2K | $102.7K | - | |
| VP | 47.0K | $45.5K | - | |
| Dir | 15.7K | $15.2K | - | |
| Dir | 15.6K | $15.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2018 | Altman Peter47 | President And CEO | Buy | 400 | $2.52 | $1,008.00 | - | |
| Nov 2, 2018 | Stertzer Simon H | Director | Buy | 2,000 | $2.53 | $5,060.00 | +200.0% | |
| Oct 30, 2018 | Altman Peter47 | President And CEO | Buy | 300 | $2.55 | $765.00 | - | |
| Oct 26, 2018 | Altman Peter47 | President And CEO | Buy | 3,850 | $2.36 | $9,079.75 | +0.3% | |
| Oct 12, 2018 | McClung David | Chief Financial Officer | Buy | 500 | $2.64 | $1,318.00 | +12.2% | |
| Oct 11, 2018 | Stertzer Simon H | Director | Buy | 1,000 | $2.70 | $2,700.00 | New | |
| Sep 25, 2018 | McClung David | Chief Financial Officer | Buy | 2,850 | $2.45 | $6,988.20 | +228.0% | |
| Sep 21, 2018 | Stertzer Simon H | Director | Buy | 1,000 | $2.43 | $2,430.00 | - | |
| Sep 20, 2018 | Altman Peter47 | President And CEO | Buy | 1,100 | $1.74 | $1,914.40 | - | |
| Sep 19, 2018 | Altman Peter47 | President And CEO | Buy | 700 | $1.65 | $1,154.00 | - |